The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Nanjing, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT | SCLC, Limited Stage | Recruiting | Not stated | 2025-12-30 | NCT07309211 | |
| An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules | Multiple Pulmonary Nodules, Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, pulmonary coin lesion, respiratory system disorder, respiratory tract neoplasm | Recruiting | Early phase 1 | 2025-12-01 | NCT07185035 | |
| A Clinical Study of HMPL-506 in Patients With Hematological Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 1 | 2025-09-29 | NCT06387082 | |
| OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM | Relapsed and/or Refractory Multiple Myeloma | Recruiting | Phase 1 / Phase 2 | 2024-05-31 | NCT06182696 |